Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Carcinoma, Ovarian”

2,253 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,253 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT00005807
What this trial is testing

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Who this might be right for
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Albert Einstein College of Medicine 40
Not applicableLooking for participantsNCT06404671
What this trial is testing

Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

Who this might be right for
Ovarian Epithelial Cancer
Alexandria University 250
Large-scale testing (Phase 3)Active Not RecruitingNCT02446600
What this trial is testing

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Transitional Cell CarcinomaFallopian Tube Undifferentiated Carcinoma+10 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Large-scale testing (Phase 3)Study completedNCT01091636
What this trial is testing

Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
National Cancer Center, Korea 184
Testing effectiveness (Phase 2)Study completedNCT00563836
What this trial is testing

Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer

Who this might be right for
Ovarian CancerEpithelial Ovarian Cancer
Neovii Biotech 41
Not applicableStudy completedNCT01832415
What this trial is testing

First Line Ovarian Cancer Treatment - Cohort Study

Who this might be right for
Epithelial Ovarian Cancer
ARCAGY/ GINECO GROUP 500
Large-scale testing (Phase 3)Study completedNCT00002568
What this trial is testing

Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Gynecologic Oncology Group 470
Early research (Phase 1)UnknownNCT02457650
What this trial is testing

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Who this might be right for
Bladder CarcinomaBreast CancerEsophagus Carcinoma+7 more
Shenzhen Second People's Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Not applicableUnknownNCT04528940
What this trial is testing

Tumor Grade Determines PD-1/PDL-1 Expression

Who this might be right for
Endometrial CancerOvarian Cancer
RWJ Barnabas Health at Jersey City Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT06087289
What this trial is testing

Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Novakand Pharma AB 18
Early research (Phase 1)Looking for participantsNCT06885697
What this trial is testing

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Who this might be right for
MesotheliomaNeoplasmsStomach Neoplasms+5 more
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Ended earlyNCT03933813
What this trial is testing

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

Who this might be right for
Epithelial Ovarian CancerAnemiaIron Deficiency Anemia
University of Wisconsin, Madison 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318
What this trial is testing

TR115 in ARID1A-Mutated Advanced Solid Tumors

Who this might be right for
Ovarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more
Tarapeutics Science Inc. 50
Testing effectiveness (Phase 2)Study completedNCT01001910
What this trial is testing

Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Albert Einstein College of Medicine 22
Testing effectiveness (Phase 2)Study completedNCT02335918
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more
Celldex Therapeutics 175
Large-scale testing (Phase 3)Study completedNCT00262990
What this trial is testing

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Novartis Pharmaceuticals 829
Not applicableNo Longer AvailableNCT03063710
What this trial is testing

Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

Who this might be right for
PSR Ovarian Cancer With a BRCA Mutation
AstraZeneca
Next Page
579